BACH1-induced ferroptosis drives lymphatic metastasis by repressing the biosynthesis of monounsaturated fatty acids

• Published in: Cell death & disease Vol. 14; no. 1; p. 48
• Main Authors: Xie, Xiufeng, Tian, Lusong, Zhao, Yan, Liu, Fang, Dai, Shuyang, Gu, Xinglu, Ye, Yuxin, Zhou, Lanping, Liu, Xinmiao, Sun, Yulin, Zhao, Xiaohang
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 20-01-2023; Springer Nature B.V; Nature Publishing Group
• Subjects: 13/1; 13/51; 14/19; 14/35; 631/67/2327; 692/699/67/322; Animal models; Animals; Antibodies; Autoantibodies; Basic-Leucine Zipper Transcription Factors - genetics; Basic-Leucine Zipper Transcription Factors - metabolism; Biochemistry; Biomedical and Life Sciences; Biosynthesis; Cell Biology; Cell Culture; Esophageal cancer; Esophageal Neoplasms - pathology; Esophageal Squamous Cell Carcinoma; Fatty acids; Fatty Acids, Monounsaturated; Ferroptosis; Ferroptosis - genetics; Genomes; Humans; Immunology; Life Sciences; Lymph nodes; Lymphatic Metastasis; Malignancy; Metastases; Metastasis; Mice; Oleic acid; Phenotypes; Protein arrays; Proteomes; Serum levels; Squamous cell carcinoma; Transcriptomics; Tumor cells; Tumorigenesis; Tumors
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-023-05571-z

Esophageal squamous cell carcinoma (ESCC) is one of the fatal malignancies worldwide. It has an increased propensity to metastasize via lymphogenous routes in an early stage. The prognosis of patients with lymph node metastases (LNM) is often worse than that of patients without metastases. Although several factors have been found to influence metastasis, the mechanisms of preference for specific metastatic routes remain poorly understood. Herein, we provide evidence that the intrinsic hypersensitivity of tumor cells to ferroptosis may proactively drive lymphatic metastasis. Serum autoantibodies associated with LNM of early ESCC were screened using a whole-proteome protein array containing 19 394 human recombinant proteins, and an anti-BACH1 autoantibody was first identified. Pan-cancer analysis of ferroptosis-related genes with preferential lymphatic metastasis and preferential hematogenous metastasis based on The Cancer Genome Atlas data was performed. Only BACH1 showed significant overexpression in tumors with preferential lymphatic metastasis, whereas it was downregulated in most tumors with preferential nonlymphatic metastasis. In addition, it was found that the serum levels of autoantibodies against BACH1 were elevated in early-stage patients with LNM. Interestingly, BACH1 overexpression and ferroptosis induction promoted LNM but inhibited hematogenous metastasis in mouse models. Transcriptomic and lipidomic analyses found that BACH1 repressed SCD1-mediated biosynthesis of monounsaturated fatty acids, especially oleic acid (OA). OA significantly attenuated the ferroptotic phenotypes and reversed the metastatic properties of BACH1-overexpressing cells. OA addition significantly rescued the ferroptotic phenotypes and reversed the metastatic properties of BACH1-overexpressing cells. Importantly, the concentration gradient of OA between primary lesions and the lymph resulted in the chemoattraction of tumor cells to promote invasion, thus facilitating lymphatic metastasis. BACH1-induced ferroptosis drives lymphatic metastasis via the BACH1-SCD1-OA axis. More importantly, this study confirms that ferroptosis is a double-edged sword in tumorigenesis and tumor progression. The clinical application of ferroptosis-associated agents requires a great caution.